RESEARCH TRIANGLE PARK, NC--(Marketwire - November 19, 2008) - Clinical trial patient
recruitment and retention has the greatest impact on clinical trial costs,
according to "Streamlining Clinical Trials"
(
www.clinicaltrialbenchmarking.com), a new study by pharmaceutical business
intelligence leader Cutting Edge Information. Not only does patient
recruitment and retention affect direct trial costs, but they also can have
a huge bottom-line impact when they delay drug trials and, ultimately, new
product launches. As a result, drug companies are increasingly relying on
high-population developing nations as a source of new study patients.
Largely untapped patient populations, along with the lower cost of running
clinical studies in many emerging countries, also has caused a surge in the
number of clinical research organizations (CROs) that are establishing
trial centers in countries such as China, India and Brazil. In a keynote
speech at the China Trials 2008 Global Clinical Development Summit in
Shanghai, Perry Nisen, M.D., Ph.D., Senior Vice President, Cancer Research
at GlaxoSmithKline, emphasized China's importance to his company reaching
goals in clinical trials. Nisen noted the influx of demand for trials in
China as being a direct cause for China's improved trial practices and
burgeoning drug development talent pool.
"As patient recruitment and retention remains one of pharma's greatest drug
development challenges, conducting clinical trials in high-population
developing countries is conducive to hitting aggressive development
timelines," says David Richardson, research team leader at Cutting Edge
Information.
"Streamlining Clinical Trials" (
www.clinicaltrialbenchmarking.com)
addresses numerous trial operations issues, including resource allocation,
performance measurement, continuous process improvement, patient and
investigator recruitment, and adaptive trial designs. Data include
clinical development budgets, clinical operations team structures and
staffing levels, performance measurement and management, clinical
operations hurdles and process improvement tools and tactics. The report
focuses on three aspects:
-- Patient Recruitment: Patient recruitment continues to dominate
clinical timelines and budgets. An entire chapter of the report is devoted
to the latest trends and tools in recruitment.
-- Budgeting and Performance Assessments: Clinical project managers must
set clear performance expectations. The report provides clinical spending
benchmarks to assist in trial budgeting and planning.
-- Clinical Operations Structure and Work Flow: Clinical trial management
team members must know their roles and responsibilities, and communication
with vendors and investigators must be seamless. The report outlines major
obstacles clinical teams face and presents real-company, proven solutions.
Contact Information: CONTACT INFORMATION:
David Richardson
919-433-0216